<DOC>
	<DOCNO>NCT01372761</DOCNO>
	<brief_summary>The purpose study ass whether multiple dos ZGN-433 safe effective .</brief_summary>
	<brief_title>Pharmacokinetics , Safety , Tolerability Efficacy Intravenous Doses ZGN-433 Obese Female Volunteers</brief_title>
	<detailed_description>This protocol design test safety efficacy drug call Beloranib ( ZGN-433 ) . It test ability reduce weight obese female subject non-childbearing potential . The study provide information much ZGN-433 get blood , long stay body , affect biological marker .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<criteria>Obese otherwise healthy female Nonchildbearing potential ( surgically sterile , postmenopausal , receive implant injectable contraceptive least 3 month ) BMI ≥ 30 ≤ 50 kg/m2 Stable body weight past month Use weight loss agent past month History eat disorder History gastric bypass surgery Current smoker</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Obese</keyword>
	<keyword>Obesity</keyword>
	<keyword>Overweight</keyword>
</DOC>